THROMBOCYTHEMIA, ESSENTIAL

Clinical trials for THROMBOCYTHEMIA, ESSENTIAL explained in plain language.

Never miss a new study

Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear

Sign up with your email to follow new studies for THROMBOCYTHEMIA, ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Blood cancer patients continue experimental drug in long-term safety trial

Disease control Completed

This study followed patients with blood cancers called myeloproliferative neoplasms who had already been taking the experimental drug bomedemstat in earlier trials. The goal was to check the long-term safety and effectiveness of continuing this daily oral medication. Researchers …

Matched conditions: THROMBOCYTHEMIA, ESSENTIAL

Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control

Last updated Apr 02, 2026 00:55 UTC

THROMBOCYTHEMIA, ESSENTIAL

Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear

Blood cancer patients continue experimental drug in long-term safety trial